Blaine Davis | Chief Financial Officer |
Carsten Brunn | President, Chief Executive Officer & Director |
Peter Traber | Chief Medical Officer |
Joseph Schwartz | SVB Securities |
Kristen Kluska | Cantor Fitzgerald |
John Newman | Canaccord Genuity |
Yun Zhong | BTIG |
Gil Blum | Needham & Company |
Tiffany Marchell | William Blair |
Boobalan Pachaiyappan | H.C. Wainwright |
Uy Ear | Mizuho |
Good morning, and welcome to the Selecta Bio Fourth Quarter 2022 Earnings Release Conference Call. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Blaine Davis, Chief Financial Officer. Please go ahead.
Thank you, and good morning, everyone.